XML 31 R44.htm IDEA: XBRL DOCUMENT v2.4.0.8
JOINT VENTURE, TECHNOLOGY LICENSE AND OTHER AGREEMENTS WITH MICRON TECHNOLOGY, INC (Details) (USD $)
3 Months Ended 9 Months Ended
Aug. 03, 2014
Jul. 28, 2013
Aug. 03, 2014
Jul. 28, 2013
Nov. 03, 2013
Related Party Transaction [Line Items]          
Variable interest entity, methodology for determining whether entity is primary beneficiary     This joint venture is a variable interest entity ("VIE") (as that term is defined in the Accounting Standards Codification ("ASC")) because all costs of the joint venture are passed on to the Company and Micron through purchase agreements they have entered into with the joint venture, and it is dependent upon the Company and Micron for any additional cash requirements. On a quarterly basis the Company reassesses whether its interest in MP Mask gives it a controlling financial interest in this VIE. The purpose of this quarterly reassessment is to identify the primary beneficiary (which is defined in the ASC as the entity that consolidates a VIE) of the VIE. As a result of the reassessment in the current quarter, the Company determined that Micron is still the primary beneficiary of the VIE, by virtue of its tie-breaking voting rights within MP Mask’s Board of Managers, thereby giving it the power to direct the activities of MP Mask that most significantly impact its economic performance, including its decision making authority in the ordinary course of business and its purchasing the majority of products produced by the VIE.    
Cost of sales $ 96,202,000 $ 82,574,000 $ 257,554,000 $ 243,206,000  
Research and development expenses 5,199,000 4,985,000 16,111,000 14,380,000  
Amount owed to MP Mask 6,700,000   6,700,000   4,500,000
Accounts receivable 102,899,000   102,899,000   73,357,000
Maximum exposure to loss from investment in VIE 93,100,000   93,100,000   93,100,000
Income (loss) from equity-method investee 100,000 0 100,000 (200,000)  
Equity Method Investee [Member]
         
Related Party Transaction [Line Items]          
Cost of sales 1,100,000 2,200,000 3,000,000 7,600,000  
Research and development expenses 200,000 200,000 700,000 700,000  
Co-venturer [Member]
         
Related Party Transaction [Line Items]          
Accounts receivable $ 9,400,000   $ 9,400,000   $ 4,900,000